OTCMKTS:IMMD - ImmuDyne Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$0.22 0.00 (0.00 %)
(As of 07/16/2018 12:42 PM ET)
Previous Close$0.22
Today's Range$0.22 - $0.22
52-Week Range$0.1810 - $0.54
Average Volume88,094 shs
Market Capitalization$9.40 million
P/E RatioN/A
Dividend YieldN/A
Immudyne, Inc., an Internet based direct response marketing company, manufactures and sells personal care and nutritional supplement products. Its products portfolio include Shapiro MD, a shampoo, conditioner, and leave-in foamer for men and women; and iNR Wellness, a daily nutritional supplement that contains yeast, oat, and mushroom beta glucans. The company sells its products worldwide through technology infrastructure and relationships with agencies, third party marketers, and online advertising platforms, as well as through its Websites inrwellness.com and shapiromd.com. The company was formerly known as Anina Resources, Inc. Immudyne, Inc. was incorporated in 1987 and is based in New York, New York.

Receive IMMD News and Ratings via Email

Sign-up to receive the latest news and ratings for IMMD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Medicinals & botanicals


Debt-to-Equity RatioN/A
Current Ratio3.87
Quick Ratio1.94


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$5.05 million
Price / Sales1.90
Cash FlowN/A
Price / CashN/A
Book Value$0.01 per share
Price / Book22.00


EPS (Most Recent Fiscal Year)N/A
Net Income$-1,200,000.00
Net Margins7.16%
Return on Equity-98.16%
Return on Assets-32.39%


Outstanding Shares43,710,000
Market Cap$9.40

The Truth About Cryptocurrencies

ImmuDyne (OTCMKTS:IMMD) Frequently Asked Questions

What is ImmuDyne's stock symbol?

ImmuDyne trades on the OTCMKTS under the ticker symbol "IMMD."

How were ImmuDyne's earnings last quarter?

ImmuDyne Inc (OTCMKTS:IMMD) announced its quarterly earnings data on Tuesday, May, 15th. The company reported ($0.01) EPS for the quarter. The business had revenue of $1.61 million for the quarter. ImmuDyne had a net margin of 7.16% and a negative return on equity of 98.16%. View ImmuDyne's Earnings History.

When is ImmuDyne's next earnings date?

ImmuDyne is scheduled to release their next quarterly earnings announcement on Monday, July, 16th 2018. View Earnings Estimates for ImmuDyne.

What is the consensus analysts' recommendation for ImmuDyne?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ImmuDyne in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Who are some of ImmuDyne's key competitors?

Who are ImmuDyne's key executives?

ImmuDyne's management team includes the folowing people:
  • Mr. Justin Schreiber, CEO, Pres & Director (Age 35)
  • Mr. Robert Kalkstein, Chief Financial Officer (Age 36)
  • Mr. Stefan Galluppi, COO, CTO & Chief Exec. Officer of Immudyne PR (Age 31)
  • Dr. Joseph V. DiTrolio M.D., Chief Medical Officer of North America & Director (Age 67)
  • Mr. Todd Goldman, Sr. VP of Marketing and Sales

Has ImmuDyne been receiving favorable news coverage?

Press coverage about IMMD stock has been trending somewhat positive on Monday, according to Accern Sentiment. Accern scores the sentiment of media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. ImmuDyne earned a news impact score of 0.05 on Accern's scale. They also gave news coverage about the company an impact score of 44.85 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

Who are ImmuDyne's major shareholders?

ImmuDyne's stock is owned by a number of of retail and institutional investors. Top institutional investors include SCHREIBER JUSTIN (16.15%). View Institutional Ownership Trends for ImmuDyne.

How do I buy shares of ImmuDyne?

Shares of IMMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ImmuDyne's stock price today?

One share of IMMD stock can currently be purchased for approximately $0.22.

How big of a company is ImmuDyne?

ImmuDyne has a market capitalization of $9.40 million and generates $5.05 million in revenue each year. ImmuDyne employs 10 workers across the globe.

How can I contact ImmuDyne?

ImmuDyne's mailing address is 1460 BROADWAY, NEW YORK NY, 10036. The company can be reached via phone at 866-351-5907.

MarketBeat Community Rating for ImmuDyne (OTCMKTS IMMD)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  19 (Vote Outperform)
Underperform Votes:  23 (Vote Underperform)
Total Votes:  42
MarketBeat's community ratings are surveys of what our community members think about ImmuDyne and other stocks. Vote "Outperform" if you believe IMMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.